Applications of translational bioinformatics in transplantation

Clinical Pharmacology and Therapeutics

Volumn 90, Issue 2, 2011, Pages 323-327

  Khatri, P ^a,b   Sarwal, M M ^a,b   Butte, A J ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BIOINFORMATICS; DRUG MANUFACTURE; GENE EXPRESSION; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; METABOLOMICS; MICROARRAY ANALYSIS; MICROFLUIDICS; MOLECULAR BIOLOGY; PEPTIDOMICS; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEOMICS; SURVIVAL TIME; SYSTEMS BIOLOGY; TECHNOLOGY; TRANSLATIONAL RESEARCH; TRANSPLANTATION;

COMPUTATIONAL BIOLOGY; DRUG DESIGN; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MEDICAL INFORMATICS APPLICATIONS; ORGAN TRANSPLANTATION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 79960594807     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.120     Document Type: Article

References (39)

1. Butte, A.J. Translational bioinformatics: coming of age. J. Am. Med. Inform. Assoc. 15, 709-714 (2008).
2. Mankoff, S.P., Brander, C., Ferrone, S. & Marincola, F.M. Lost in Translation: Obstacles to Translational Medicine. J. Transl. Med. 2, 14 (2004).
3. Kaitin, K.I. & DiMasi, J.A. Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009. Clin. Pharmacol. Ther. 89, 183-188 (2011).
4. Dudley, J.T., Schadt, E., Sirota, M., Butte, A.J. & Ashley, E. Drug discovery in a multidimensional world: systems, patterns, and networks. J. Cardiovasc. Transl. Res. 3, 438-447 (2010).
5. Lechler, R.I., Sykes, M., Thomson, A.W. & Turka, L.A. Organ transplantation-how much of the promise has been realized? Nat. Med. 11, 605-613 (2005). (Pubitemid 40868300)
6. Khatri, P. & Sarwal, M.M. Using gene arrays in diagnosis of rejection. Curr. Opin. Organ Transplant. 14, 34-39 (2009).
7. Khatri, P. & Sarwal, M.M. Functional pathway analysis for understanding immunologic signature of rejection: current approaches and outstanding challenges. In Immunologic Signatures of Rejection (eds. Marincola, F.M. & Wang, E.) (Springer, New York, 2010).
8. S arwal, M. et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N. Engl. J. Med. 349, 125-138 (2003). (Pubitemid 36818782)
9. Mueller, T.F. et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am. J. Transplant. 7, 2712-2722 (2007). (Pubitemid 350045779)
10. Pham, M.X. et al.; IMAG E Study Group. Gene-expression profiling for rejection surveillance after cardiac transplantation. N. Engl. J. Med. 362, 1890-1900 (2010).
11. Sutherland, S.M. et al. Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients. Kidney Int. 76, 1277-1283 (2009).
12. Butte, A.J., Sigdel, T.K., Wadia, P.P., Miklos, D.B. & Sarwal, M.M. Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal disease. Mol. Cell Proteomics 10, M110.000497 (2011).
13. Sigdel, T.K. et al. Shotgun proteomics identifies proteins specific for acute renal transplant rejection. Proteomics. Clin. Appl. 4, 32-47 (2010).
14. Ling, X.B. et al. Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J. Am. Soc. Nephrol. 21, 646-653 (2010).
15. Sigdel, T.K. & Sarwal, M.M. The proteogenomic path towards biomarker discovery. Pediatr. Transplant. 12, 737-747 (2008).
16. Domanski, L. et al. Hypoxanthine as a graft ischemia marker stimulates catalase activity in the renal vein during reperfusion in humans. Transplant. Proc. 38, 35-38 (2006).
17. Vollenbroeker, B., Koch, J.H., Fobker, M., Suwelack, B., Hohage, H. & Müller, U. Determination of cyclosporine and its metabolites in blood via HPLC-MS and correlation to clinically important parameters. Transplant. Proc. 37, 1741-1744 (2005). (Pubitemid 40790816)
18. Annesley, T.M. & Clayton, L.T. Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry. Clin. Chem. 51, 872-877 (2005). (Pubitemid 40577924)
19. Wishart, D.S. Metabolomics in monitoring kidney transplants. Curr. Opin. Nephrol. Hypertens. 15, 637-642 (2006). (Pubitemid 44607437)
20. Anglicheau, D. et al. MicroRNA expression profiles predictive of human renal allograft status. Proc. Natl. Acad. Sci. U.S.A. 106, 5330-5335 (2009).
21. Shi, L. et al.; MAQC Consortium. The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 24, 1151-1161 (2006). (Pubitemid 44359727)
22. Morgan, A.A., Khatri, P., Jones, R.H., Sarwal, M.M. & Butte, A.J. Comparison of multiplex meta analysis techniques for understanding the acute rejection of solid organ transplants. BMC Bioinformatics 11 Suppl 9, S6 (2010).
23. Chen, R. et al. Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions. PLoS Comput. Biol. 6, pii: e1000940 (2010).
24. Wang, E., Worschech, A. & Marincola, F.M. The immunologic constant of rejection. Trends Immunol. 29, 256-262 (2008).
25. Li, L. et al. Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc. Natl. Acad. Sci. U.S.A. 106, 4148-4153 (2009).
26. Pascual, M., Theruvath, T., Kawai, T., Tolkoff-Rubin, N. & Cosimi, A.B. Strategies to improve long-term outcomes after renal transplantation. N. Engl. J. Med. 346, 580-590 (2002). (Pubitemid 34438820)
27. Suntharalingam, G. et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TG N1412. N. Engl. J. Med. 355, 1018-1028 (2006). (Pubitemid 44343545)
28. Puellmann, K., Beham, A.W. & Kaminski, W.E. Cytokine storm and an anti-CD28 monoclonal antibody. N. Engl. J. Med. 355, 2592-3; author reply 2593 (2006). (Pubitemid 44917515)
29. Butcher, E.C., Berg, E.L. & Kunkel, E.J. Systems biology in drug discovery. Nat. Biotechnol. 22, 1253-1259 (2004). (Pubitemid 39336778)
30. S uthram, S., Dudley, J.T., Chiang, A.P., Chen, R., Hastie, T.J. & Butte, A.J. Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput. Biol. 6, e1000662 (2010).
31. Yang, X. et al. Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nat. Genet. 41, 415-423 (2009).
32. Butte, A.J., Tamayo, P., Slonim, D., Golub, T.R. & Kohane, I.S. Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. Proc. Natl. Acad. Sci. U.S.A. 97, 12182-12186 (2000).
33. Barabasi, A.L. & Albert, R. Emergence of scaling in random networks. Science 286, 509-512 (1999).
34. Jeong, H., Mason, S.P., Barabási, A.L. & Oltvai, Z.N. Lethality and centrality in protein networks. Nature 411, 41-42 (2001). (Pubitemid 32428180)
35. Taylor, I.W. et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat. Biotechnol. 27, 199-204 (2009).
36. Ashley, E.A. et al. Network analysis of human in-stent restenosis. Circulation 114, 2644-2654 (2006). (Pubitemid 44967348)
37. Schadt, E.E. Molecular networks as sensors and drivers of common human diseases. Nature 461, 218-223 (2009).
38. Merali, Z. Computational science:.Error. Nature 467, 775-777 (2010).
39. Bauer-Mehren, A., Furlong, L.I. & Sanz, F. Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Mol. Syst. Biol. 5, 290 (2009).